Research Topics
| S PallantiSummaryAffiliation: Mount Sinai School of Medicine Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Relapse in young paranoid schizophrenic patients: a prospective study of stressful life events, P300 measures, and copingS Pallanti
Institute for Neurosciences, Florence, Italy
Am J Psychiatry 154:792-8. 1997..The authors investigated the relationship of cognitive and coping characteristics to stressful life events at the time of relapse in patients with recent-onset paranoid schizophrenia...- Social anxiety in outpatients with schizophrenia: a relevant cause of disabilityStefano Pallanti
Department of Neurological and Psychiatric Sciences, University of Florence, Italy
Am J Psychiatry 161:53-8. 2004.... - Treatment non-response in OCD: methodological issues and operational definitionsStefano Pallanti
Mount Sinai School of Medicine, New York, NY, USA
Int J Neuropsychopharmacol 5:181-91. 2002..Better characterization of which patients respond and do not respond to various treatments will enable more accurate clustering of patients, and help facilitate multi-site data collection for future research trials... - Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot studyStefano Pallanti
Institute for Neurosciences, Florence, Italy
J Clin Psychiatry 65:1394-9. 2004..The present study was undertaken to determine whether the mirtazapine-citalopram combination could induce an earlier and/or greater effect on the 5-HT system in OCD subjects than citalopram alone... - Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic linesStefano Pallanti
Mount Sinai School of Medicine, New York, New York, USA
Prog Neuropsychopharmacol Biol Psychiatry 30:400-12. 2006..The authors reviewed also the more recent therapeutic pharmacological and psychological lines for the treatment of refractoriness in OCD... - The emergence of social phobia during clozapine treatment and its response to fluoxetine augmentationS Pallanti
Istituto di Neuroscienze, University of Florence Medical School, Italy
J Clin Psychiatry 60:819-23. 1999..The atypical neuroleptic clozapine has been reported to induce anxiety symptoms, probably owing to its effect on serotonergic pathways. We report 12 cases of schizophrenic patients who developed social phobia during clozapine treatment... - Effects of clozapine on awareness of illness and cognition in schizophreniaS Pallanti
Istituto di Neuroscienze, Centro di Neurologia, Psichiatria e Psicologia Clinica S r l, Florence, Italy
Psychiatry Res 86:239-49. 1999..The results confirm the effectiveness of clozapine not only in enhancing neurocognitive function, but also in increasing awareness of illness in schizophrenic patients... - Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorderS Pallanti
Neurosciences Institute, Florence, Italy
Am J Psychiatry 156:1094-6. 1999..The authors' goal was to investigate the awareness of illness and subjective cognitive complaints of patients with either bipolar I disorder or bipolar II disorder during a phase of clinical stabilization... - Eye movement abnormalities in anorexia nervosaS Pallanti
Istituto di Neuroscienze and University of Florence Medical School, Italy
Psychiatry Res 78:59-70. 1998..Results are in agreement with the hypothesis regarding the persistence of neurophysiological as well as psychopathological traits of disorder in anorectic patients... - Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trialStefano Pallanti
Istituto di Neuroscienze, and University of Florence, School of Medicine, Italy
J Clin Psychiatry 63:796-801. 2002..The selective serotonin reuptake inhibitor citalopram is effective for OCD when administered orally. We investigated whether intravenous citalopram would rapidly benefit OCD patients unresponsive to orally administered SRIs... 
Low-frequency rTMS over right dorsolateral prefrontal cortex in the treatment of resistant depression: cognitive improvement is independent from clinical response, resting motor threshold is related to clinical responseS Pallanti
Department of Psychiatry, Mount Sinai School of Medicine, Bronx, New York, NY, USA
Neuropsychobiology 65:227-35. 2012..We investigated the clinical, cognitive and neurophysiologic effects of a 3 weeks' protocol of low-frequency rTMS applied over the right DLPFC in resistant depression...
The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)S Bernardi
Department of Psychiatry, Columbia University New York State Psychiatric Institute, New York, NY, USA
Psychol Med 42:875-87. 2012....- Ondansetron augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary, single-blind, prospective studyStefano Pallanti
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA
CNS Drugs 23:1047-55. 2009..Trial registration number (ClinicalTrials.gov): NCT00796497... - Major depression and bipolar disorders in CADASIL: a study using the DSM-IV semi-structured interviewR Valenti
Department of Neurological and Psychiatric Sciences, University of Florence, Italy
Acta Neurol Scand 124:390-5. 2011..Although recognized as a cardinal feature of the disease, psychiatric disturbances have rarely been the object of focused studies. We performed a structured evaluation of mood disorders in CADASIL... - Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled studyEric Hollander
Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY, USA
Int J Neuropsychopharmacol 6:397-401. 2003..Risperidone may be an effective and well-tolerated augmentation strategy in treatment-resistant OCD subjects, but larger sample size studies are required to demonstrate this... - Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression?S Pallanti
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Neuroscience 167:323-8. 2010..To confirm and extend these findings further studies require a longer follow-up period, supported by biological observation and replication... - Refractory obsessive-compulsive disorder: state-of-the-art treatmentEric Hollander
Department of Psychiatry, Compulsive, Impulsive, and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 63:20-9. 2002..The authors synthesize state-of-the-art treatment and give practical advice for clinicians... - Positron emission tomography imaging of risperidone augmentation in serotonin reuptake inhibitor-refractory patientsMonte S Buchsbaum
Mount Sinai School of Medicine, New York, NY 10029, USA
Neuropsychobiology 53:157-68. 2006..Our results are consistent with a frontostriatal circuit change related to both dopaminergic and serotonergic systems and with the presence of psychopharmacological subtypes within OCD... - Autoimmune markers in vitiligo patients appear correlated with obsession and phobiaS Moretti
Department of Critical Care Medicine and Surgery, Division of Dermatology, University of Florence, Florence, Italy
J Eur Acad Dermatol Venereol 26:861-7. 2012.... - Emotional arousal and phobia in transient global amnesiaD Inzitari
Department of Neurological and Psychiatric Sciences, University of Florence, Italy
Arch Neurol 54:866-73. 1997..To evaluate the role of emotionally stressful or phobogenic events and phobic personality traits in transient global amnesia (TGA)... - Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?Eric Hollander
Compulsive, Impulsive, and Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
Am J Psychiatry 162:137-45. 2005..To the authors' knowledge, this is the first placebo-controlled treatment study in pathological gamblers with bipolar spectrum disorders; it compares sustained-release lithium carbonate to placebo... - A qualitative analysis of nonresponse: management of treatment-refractory obsessive-compulsive disorderStefano Pallanti
Department of Psychiatry, University of Florence, Italy
J Clin Psychiatry 65:6-10. 2004..More results are needed before the effectiveness of the nonpharmacologic treatments for OCD can be determined... - Lithium and valproate treatment of pathological gambling: a randomized single-blind studyStefano Pallanti
Mount Sinai School of Medicine, New York, NY, USA
J Clin Psychiatry 63:559-64. 2002..The aim of the present study was to evaluate the efficacy and safety of lithium and valproate in nonbipolar pathological gamblers... - Cognitive event-related potentials differentiate schizophrenia with obsessive-compulsive disorder (schizo-OCD) from OCD and schizophrenia without OC symptomsStefano Pallanti
Institute for Neurosciences, Viale Ugo Bassi, Firenze 50137, Italy
Psychiatry Res 170:52-60. 2009..Neurobiological underpinnings deserve further considerations and might drive to a definition of a distinctive endophenotype for schizo-OCD in the de-construction of the schizophrenia endophenotype... - Detecting attention-deficit/hyperactivity disorder (ADHD) in adults with intellectual disability The use of Conners' Adult ADHD Rating Scales (CAARS)G La Malfa
Department of Neurological and Psychiatric Sciences, University of Florence, Florence, Italy
Res Dev Disabil 29:158-64. 2008..Therefore, not only can ADHD be a valid psychiatric diagnosis for a child with ID but for an adult with ID as well. The CAARS can be considered a useful clinical instrument to survey ADHD in ID... - Attachment processes in eating disordersA Ramacciotti
Istituto di Neuroscienze, , Italy
Eat Weight Disord 6:166-70. 2001..An inference is none the less made with regard to the role of psychotherapy in these results... - Bipolar disorder and comorbid attention deficit hyperactivity disorder. A distinct clinical phenotype? Clinical characteristics and temperamental traitsSilvia Bernardi
Department of Psychiatry, Mount Sinai School of Medicine, New York 10029, USA
World J Biol Psychiatry 11:656-66. 2010..We further hypothesize that maladaptive temperament will be associated with the severity of both illnesses... - Internet addiction: a descriptive clinical study focusing on comorbidities and dissociative symptomsSilvia Bernardi
Department of Psychiatry, Mount Sinai School of Medicine, Manhattan, NY, USA
Compr Psychiatry 50:510-6. 2009..The detachment has been suggested as a reason for the attractiveness of the Internet; thus, we assessed dissociative symptoms and their association with IAD disability... - Nefazodone treatment of pathological gambling: a prospective open-label controlled trialStefano Pallanti
Department of Psychiatry, Mount Sinai School of Medicine, New York, N.Y, USA
J Clin Psychiatry 63:1034-9. 2002..Side effects (dry mouth and sedation) of moderate severity occurred in 4 subjects. CONCLUSION: These preliminary results suggest that nefazodone may be effective in reducing symptoms of pathological gambling and is well tolerated... - Obsessive-compulsive disorder spectrum as a scientific "metaphor"Stefano Pallanti
Strategic Center of Excellence of Psychiatry, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
CNS Spectr 13:6-15. 2008..By increasing research in this field, the OCD spectrum may evolve from a fragmented level of conceptualization as a "metaphor" to one that is more comprehensive and structured... - Pharmacological treatments of pathological gamblingEric Hollander
Department of Psychiatry, Compulsive, Impulsive and Anxiety Disorders Program, Mount Sinai School of Medicine, Box 1230, One Gustave L Levy Place, New York, NY, USA
J Gambl Stud 21:99-110. 2005..This review focuses on recent research examining the treatment of pathological gambling and highlights methodological challenges for future studies... - Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS)Stefano Pallanti
Mount Sinai School of Medicine, New York, NY 10029, USA
J Gambl Stud 21:431-43. 2005..PG-YBOCS thus appears to be a reliable and valid measure of pathological gambling severity, and can be regarded as an important tool for clinicians and researchers treating pathological gamblers... - Neurobiology of repeated transcranial magnetic stimulation in the treatment of anxiety: a critical reviewStefano Pallanti
Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY 10029, USA
Int Clin Psychopharmacol 24:163-73. 2009..The neurobiological correlates suggest possible efficacy for the treatment of social anxiety that still has to be investigated... - Brain plasticity and brain stimulation in neuropsychiatry: toward individualized medicineStefano Pallanti
Strategic Center of Excellence of Psychiatry, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
CNS Spectr 13:287-92. 2008 - The Shorter PROMIS Questionnaire and the Internet Addiction Scale in the assessment of multiple addictions in a high-school population: prevalence and related disabilityStefano Pallanti
Department of Psychiatry, Institute for Neuroscience, Florence University of Medicine, Florence, Italy
CNS Spectr 11:966-74. 2006.... - Kleptomania: clinical features and comorbidity in an Italian sampleSilvio Presta
Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa, Via Roma 67, 56100 Pisa, Italy
Compr Psychiatry 43:7-12. 2002..Family history also showed a high prevalence of psychiatric disorders. Our study indicates clear connections between kleptomania and different psychiatric disorders, the exact nature of which has yet to be clarified... - [Validity and reliability of Quality of Life, Enjoyment and Satisfaction Questionnaire, Short Form]Paola Rucci
Deipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotechnologie,
Epidemiol Psichiatr Soc 16:82-9. 2007 - Transcultural observations of obsessive-compulsive disorderStefano Pallanti
Am J Psychiatry 165:169-70. 2008 - Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorderNaomi A Fineberg
Postgraduate School of Medicine, University of Hertfordshire, Hatfield, Herts, UK
Int Clin Psychopharmacol 22:313-22. 2007..Viewed collectively, these results suggest that selective serotonin reuptake inhibitors are effective long-term treatments and relapse prevention represents the treatment target for obsessive-compulsive disorder...